Aquestive Therapeutics Inc. (AQST) Misses Q3 EPS by 1c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q3 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $13.54 million versus the consensus estimate of $12.74 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities